Tagged as: Toujou

CVS Replaces Lantus® With Basaglar®

It has been reported that U.S. pharmacy benefit manager CVS will drop Sanofi’s insulin drugs, Lantus® (insulin glargine injection, 100 units/ml) and Toujeo® (insulin glargine injection, 300 units/ml) from the list of medications for which it reimburses on behalf of health insurers.  In July CVS caremark® published a list of…

Read More